Literature DB >> 7665808

Mixed anxiety-depression in a primary-care clinic.

M B Stein1, P Kirk, V Prabhu, M Grott, M Terepa.   

Abstract

To determine the prevalence and clinical significance of a mixed anxiety-depressive (MAD) syndrome in primary care, a two-stage sampling design was applied to 796 consecutive clinic attendees without known psychiatric illness. Among 78 systematically interviewed subjects, 10.3% (n = 8) had a depressive disorder alone, 12.8% (n = 10) had an anxiety disorder alone, 19.2% (n = 15) had a comorbid anxiety and depressive disorder and 12.8% (n = 10) had a combination of subsyndromal anxiety and depressive features that fulfilled either ICD-10 or our own operational criteria for MAD. Patients with MAD rated their disability as being comparable to that of patients with anxiety or depressive disorders. These findings lend support to the notion that there is a sizeable subgroup of patients in primary care who appear to be suffering from a psychiatric syndrome with an admixture of subsyndromal depressive and anxiety features. Questions about the temporal stability of MAD and preferred approaches to treatment have yet to be answered.

Entities:  

Mesh:

Year:  1995        PMID: 7665808     DOI: 10.1016/0165-0327(95)00002-5

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  15 in total

1.  The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys.

Authors:  Laura Andrade; Jorge J Caraveo-Anduaga; Patricia Berglund; Rob V Bijl; Ron De Graaf; Wilma Vollebergh; Eva Dragomirecka; Robert Kohn; Martin Keller; Ronald C Kessler; Norito Kawakami; Cengiz Kiliç; David Offord; T Bedirhan Ustun; Hans-Ulrich Wittchen
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

Review 2.  The diagnosis and management of depression and anxiety in primary care: the need for a different framework.

Authors:  K S Jacob
Journal:  Postgrad Med J       Date:  2006-12       Impact factor: 2.401

3.  Identification of distinct depressive symptom trajectories in women following surgery for breast cancer.

Authors:  Laura B Dunn; Bruce A Cooper; John Neuhaus; Claudia West; Steven Paul; Bradley Aouizerat; Gary Abrams; Janet Edrington; Debby Hamolsky; Christine Miaskowski
Journal:  Health Psychol       Date:  2011-07-04       Impact factor: 4.267

Review 4.  Optimal management of anxiety in older patients.

Authors:  K J Weiss
Journal:  Drugs Aging       Date:  1996-09       Impact factor: 3.923

5.  Reliability and validity of the Symptoms of Depression Questionnaire (SDQ).

Authors:  Paola Pedrelli; Mark A Blais; Jonathan E Alpert; Richard C Shelton; Rosemary S W Walker; Maurizio Fava
Journal:  CNS Spectr       Date:  2014-10-02       Impact factor: 3.790

6.  Major depression symptoms in primary care and psychiatric care settings: a cross-sectional analysis.

Authors:  Bradley N Gaynes; A John Rush; Madhukar H Trivedi; Stephen R Wisniewski; G K Balasubramani; Donald C Spencer; Timothy Petersen; Michael Klinkman; Diane Warden; Linda Nicholas; Maurizio Fava
Journal:  Ann Fam Med       Date:  2007 Mar-Apr       Impact factor: 5.166

7.  Rates of detection of mood and anxiety disorders in primary care: a descriptive, cross-sectional study.

Authors:  Monica Vermani; Madalyn Marcus; Martin A Katzman
Journal:  Prim Care Companion CNS Disord       Date:  2011

8.  Experience of the use of velaxin (venlafaxine) in anxious depression.

Authors:  N A Il'ina
Journal:  Neurosci Behav Physiol       Date:  2009-03

Review 9.  Defining anxious depression: a review of the literature.

Authors:  Dawn F Ionescu; Mark J Niciu; Ioline D Henter; Carlos A Zarate
Journal:  CNS Spectr       Date:  2013-03-14       Impact factor: 3.790

10.  Anxiety and depression in the working population using the HAD Scale--psychometrics, prevalence and relationships with psychosocial work characteristics.

Authors:  H Andrea; U Bültmann; A J H M Beurskens; G M H Swaen; C P van Schayck; I J Kant
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2004-08       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.